Revenue from Contracts with Customers (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table summarizes revenue by revenue source as follows:

	Year Ended December 31,
Major Products/Service Lines (in thousands)	2023		2022		2021
Product revenue, net(1)	$	1,263,068	$	887,038	$	400,356
License and royalty revenues(2)	33,361		48,023		24,852
Total revenues	$	1,296,429	$	935,061	$	425,208

______________________________

(1)The Company’s product revenue includes PYLARIFY and DEFINITY, among other products. This category represents the delivery of physical goods. The Company applies the same revenue recognition policies and judgments for all of its principal products.

(2)The Company recognized $24.0 million license revenue in the first quarter of 2022 related to an agreement with Novartis Pharma AG.

Revenue by product category on a net basis is as follows:

	Year Ended December 31,
(in thousands)	2023		2022		2021
PYLARIFY	$	851,303	$	527,405	$	43,414
Other radiopharmaceutical oncology	3,130		4,102		5,473
Total radiopharmaceutical oncology	854,433		531,507		48,887
DEFINITY	279,768		244,993		232,759
TechneLite	87,370		88,864		91,293
Other precision diagnostics	22,980		22,825		26,973
Total precision diagnostics	390,118		356,682		351,025
Strategic Partnerships and other revenue	51,878		46,872		25,296
Total revenues	$	1,296,429	$	935,061	$	425,208

Schedule of Valuation and Qualifying Accounts

An analysis of the amount of, and change in, reserves is summarized as follows:

(in thousands)	Rebates and Allowances
Balance, January 1, 2022	$	10,977
Provision related to current period revenues	26,683
Adjustments relating to prior period revenues	70
Payments or credits made during the period	(24,331)
Balance, December 31, 2022	13,399
Provision related to current period revenues	32,308
Adjustments relating to prior period revenues	(453)
Payments or credits made during the period	(29,184)
Balance, December 31, 2023	$	16,070

Schedule of contracts with customer

The Company recognized certain revenues as follows:

	Year Ended December 31,
(in thousands)	2023		2022
Amounts included in the contract liability at the beginning of the period	$	682	$	244